(Q37851064)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387287%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

review article

1 reference

title

Imatinib as adjuvant therapy for gastrointestinal stromal tumors: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387287%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387287%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Katy L. Cooper

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387287%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Munira Essat

series ordinal

1

1 reference

24 August 2017

Katy Cooper

series ordinal

2

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387287%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

24 January 2020

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387287%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387287%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387287%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

2202-2214

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387287%20AND%20SRC:MED&resulttype=core&format=json

The role of adjuvant and neoadjuvant therapy in gastrointestinal stromal tumors

24 January 2020

cites work

1 reference

Gastrointestinal stromal tumors and leiomyosarcomas

21 January 2018

1 reference

Recent advances in therapy for gastrointestinal stromal tumors

21 January 2018

1 reference

Improved insight into resistance mechanisms to imatinib in gastrointestinal stromal tumors: a basis for novel approaches and individualization of treatment

21 January 2018

1 reference

Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study.

21 January 2018

1 reference

Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation

21 January 2018

1 reference

Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection.

21 January 2018

1 reference

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

21 January 2018

1 reference

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

21 January 2018

1 reference

Gastrointestinal stromal tumor workshop.

21 January 2018

1 reference

Management of gastrointestinal stromal tumors in the imatinib era: selected case studies

21 January 2018

1 reference

Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy

21 January 2018

1 reference

Surgical outcomes of patients with gastrointestinal stromal tumors in the era of targeted drug therapy.

21 January 2018

1 reference

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST).

21 January 2018

1 reference

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients.

21 January 2018

1 reference

Spontaneous intratumoral bleeding and rupture of giant gastric stromal tumor (> 30 cm) in a young patient

21 January 2018

1 reference

Gastrointestinal stromal tumor of the stomach with a giant abscess penetrating the gastric lumen

21 January 2018

1 reference

Isolated abdominal wound metastasis from a gastrointestinal stromal tumor

21 January 2018

1 reference

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.

21 January 2018

1 reference